Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions
- Follicular Lymphoma
- Marginal Zone B-Cell Lymphoma
- MALT Lymphoma
- Lymphoma of Mucosa-Associated Lymphoid Tissue
- Lymphoma, Small Lymphocytic
- Waldenstrom Macroglobulinemia
- Mantle-Cell Lymphoma
Interventions
- DRUG: Lenalidomide
- DRUG: Dexamethasone
- DRUG: Rituximab
Sponsor
Abramson Cancer Center at Penn Medicine